JPRN-UMIN000031523已完成未知
A study on efficacy and safety of Edoxaban on high-risk gastrointestinal endoscopic procedures - Edoxaban study
iigata University Graduate School of Medical and Dental Sciences0 个研究点目标入组 12 人开始时间: 2018年3月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with clinical bleeding tendency 2) Patient during the other antithrombotic agent except warfarin or edoxaban 3) Allergy to DOAC 4) Patient during azole antifungal drugs 5) Pregnant or lactation woman 6) Patient with mitral stenosis or replacement of the artificial valve 7) Patient with a history of cardioembolic ischemic stroke 8) Patient with a history of ischemic stroke or TIA 9) Patient with anti-phospholipid antibody syndrome 10) Patient with a history of deep vein thrombosis or pulmonary embolism 11) Patients who are disqualified for the study by physicians 12) Patient with contraindication for edoxaban
研究者
相似试验
已完成
不适用
Clinical study on the usefullness of edoxaban tosilate hydrate to portal vein thrombosis complicated with chronic liver diseasePortal vein thrombosisJPRN-UMIN000030108Kanazawa University Hospital20
进行中（未招募）
1 期
EDOXABAN TREATMENT VERSUS VKA IN PATIENTS WITH AF UNDERGOING PCI.MedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersEUCTR2016-002683-14-NLDaiichi Sankyo Europe GmbH1,506
进行中（未招募）
1 期
EDOXABAN TREATMENT VERSUS VKA IN PATIENTS WITH AF UNDERGOING PCI.EUCTR2016-002683-14-ATDaiichi Sankyo Europe GmbH1,500
进行中（未招募）
1 期
EDOXABAN TREATMENT VERSUS VKA IN PATIENTS WITH AF UNDERGOING PCI.EUCTR2016-002683-14-LTDaiichi Sankyo Europe GmbH1,500
进行中（未招募）
1 期
EDOXABAN TREATMENT VERSUS VKA IN PATIENTS WITH AF UNDERGOING PCI.EUCTR2016-002683-14-HUDaiichi Sankyo Europe GmbH1,500